Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement

Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement

The protection of current influenza vaccines is limited due to the viral antigenic shifts and antigenic drifts. The universal influenza vaccine is a new hotspot in vaccine research that aims to overcome these problems. Polydopamine (PDA), a versatile biomaterial, has the advantages of an excellent b...

Full description

Bibliographic Details
Main Authors: Yongqing Liu, Xiaoli Wang, Jiangfei Zhou, Shuaibing Shi, Tengfei Shen, Liangliang Chen, Min Zhang, Chengshui Liao, Chen Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
polydopamine
nanoconjugates
nano BPP-V epitope vaccine
nano BP-IV epitope vaccine
H9N2 avian influenza virus
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.693972/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.693972/full

Similar Items